Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Canadian Journal of Pain = Revue Canadienne De La Douleur
|
June 4, 2024
Attending to Marginalization in The Chronic Pain Literature: A Scoping Review
Laura Connoy, Michelle Solomon, Riana Longo, et al.
The Journal of Pediatrics
|
July 16, 2017
Examining the Role of the Pediatric Emergency Department in Reducing Unintended Adolescent Pregnancy
Michelle Solomon, Gia M Badolato, Lauren S Chernick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2019
The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis
Hussien Al-Shamma, Karin Lehmann-Bruinsma, Chris Carroll, et al.
Pharmacological Research
|
February 23, 2018
Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor
Ibragim Gaidarov, Todd Anthony, Joel Gatlin, et al.
The Journal of Investigative Dermatology
|
May 7, 2026
MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic Dermatitis
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Work (Reading, Mass.)
|
November 27, 2014
Seeking and securing work: Individual-level predictors of employment of psychiatric survivors
Peter V Hall, Phyllis Montgomery, Samantha Davie, et al.
Iscience
|
October 11, 2022
Achieving an 80% carbon-free electricity system in China by 2035
Nikit Abhyankar, Jiang Lin, Fritz Kahrl, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2017
Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub> Agonist for the Treatment of Chronic Pain
Sangdon Han, Lars Thoresen, Jae-Kyu Jung, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2011
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonists
Daniel Buzard, Sangdon Han, Lars Thoresen, et al.
The Journal of Allergy and Clinical Immunology
|
July 6, 2024
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Canadian Journal of Pain = Revue Canadienne De La Douleur
|
June 4, 2024
Attending to Marginalization in The Chronic Pain Literature: A Scoping Review
Laura Connoy, Michelle Solomon, Riana Longo, et al.
The Journal of Pediatrics
|
July 16, 2017
Examining the Role of the Pediatric Emergency Department in Reducing Unintended Adolescent Pregnancy
Michelle Solomon, Gia M Badolato, Lauren S Chernick, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 16, 2019
The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis
Hussien Al-Shamma, Karin Lehmann-Bruinsma, Chris Carroll, et al.
Pharmacological Research
|
February 23, 2018
Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor
Ibragim Gaidarov, Todd Anthony, Joel Gatlin, et al.
The Journal of Investigative Dermatology
|
May 7, 2026
MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic Dermatitis
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Work (Reading, Mass.)
|
November 27, 2014
Seeking and securing work: Individual-level predictors of employment of psychiatric survivors
Peter V Hall, Phyllis Montgomery, Samantha Davie, et al.
Iscience
|
October 11, 2022
Achieving an 80% carbon-free electricity system in China by 2035
Nikit Abhyankar, Jiang Lin, Fritz Kahrl, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2017
Discovery of APD371: Identification of a Highly Potent and Selective CB<sub>2</sub> Agonist for the Treatment of Chronic Pain
Sangdon Han, Lars Thoresen, Jae-Kyu Jung, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 20, 2011
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonists
Daniel Buzard, Sangdon Han, Lars Thoresen, et al.
The Journal of Allergy and Clinical Immunology
|
July 6, 2024
Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists
Joshua Wollam, Michelle Solomon, Christiane Villescaz, et al.
Page
of 3